We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 29, 2020

MDM2 Is a Novel Interactor of the VHL Tumor Suppressor

Scientific reports


Additional Info

Scientific reports
The E3 Ubiquitin-Protein Ligase MDM2 Is a Novel Interactor of the Von Hippel-Lindau Tumor Suppressor
Sci Rep 2020 Sep 28;[EPub Ahead of Print], A Falconieri, G Minervini, R Bortolotto, D Piovesan, R Lopreiato, G Sartori, M Pennuto, SCE Tosatto

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading